CER Groupe Departement Sante

Belgium

CER Groupe Departement Sante

Belgium
SEARCH FILTERS
Time filter
Source Type

Thomas A.,German Sport University Cologne | Walpurgis K.,German Sport University Cologne | Delahaut P.,CER Groupe Departement Sante | Fichant E.,CER Groupe Departement Sante | And 2 more authors.
Growth Hormone and IGF Research | Year: 2017

According to the regulations of the World Anti-Doping Agency (WADA), growth promoting peptides such as the insulin-like growth factor-I (IGF-I) and its synthetic analogues belong to the class of prohibited compounds. While several assays to quantify endogenous IGF-I have been established, the potential misuse of synthetic analogues such as LongR3-IGF-I, R3-IGF-I and Des1-3-IGF-I remains a challenge and superior pharmacokinetic properties have been described for these analogues. Within the present study, it was demonstrated that the target peptides can be successfully detected in plasma samples by means of magnetic beads-based immunoaffinity purification and subsequent nanoscale liquid chromatographic separation with high resolution mass spectrometric detection. Noteworthy, the usage of a specific antibody for LongR3-IGF-I enables the determination in low ng/mL levels despite the presence of an enormous excess of endogenous human IGF-I. In addition, different metabolism studies (in-vitro and in-vivo) were performed using sophisticated strategies such as incubation with skin tissue microsomes, degradation in biological fluids (for all analogues), and administration to rats (for LongR3-IGF-I). Herewith, several C-and N-terminally truncated metabolites were identified and their relevancy was additionally confirmed by in-vivo experiments with rodents. Especially for LongR3-IGF-I, a metabolite ((Des1-11)-LongR3-IGF-I) was identified that prolonged the detectability in-vivo by a factor of approximately 2. The method was validated for qualitative interpretation considering the parameters specificity, identification capability, recovery (26–60%), limit of detection (0.5 ng/mL), imprecision (< 25%), linearity, stability, and matrix effects. A stable isotope labelled (15N)-IGF-I was used as internal standard to control all sample preparation steps. © 2017

Loading CER Groupe Departement Sante collaborators
Loading CER Groupe Departement Sante collaborators